534.3000 13.85 (2.66%)
NSE Jan 22, 2026 15:57 PM
Volume: 42,993
 

534.30
2.66%
Axis Direct
Considering overall stellar performance we have incresed earnings for FY22E & FY23E and increased target price to INR 1,670 with Buy recommendations.
Promoters unpledged 9.28% of shares in last quarter. Total pledge stands at 26.04% of promoter holdings
More from Solara Active Pharma Sciences Ltd.
Recommended